Oxidative Stress Causes Increased Amyloid Peptide Levels through Telomeric Protein, RAP1

This research identifies a novel, extratelomeric role for the telomere protection factor RAP1 (TERF2IP) in modulating amyloid precursor protein (APP) processing through interactions with GFAPɛ and presenilin-1 (PS1). Alzheimer’s disease (AD) is characterized by accumulation of amyloid β (Aβ) peptides, produced by γ-secretase cleavage of APP C99 fragments; the balance between soluble Aβ40 and the more aggregation-prone Aβ42 is critical for disease risk. The study connects RAP1, historically understood as a nuclear telomere-associated protein, with cytoplasmic processes relevant to age-related neurodegeneration.

Using biochemical and cellular approaches, the team demonstrates that GFAPɛ, an astrocyte-enriched isoform of glial fibrillary acidic protein found in the subventricular zone and associated with reactive astrocytes near amyloid plaques, interacts with RAP1. GFAPɛ also interacts with the N-terminal, cytoplasmic domains of PS1, a catalytic presenilin subunit of γ-secretase implicated in early-onset AD when mutated. The authors provide evidence that RAP1 can bind PS1 directly or form complexes with PS1 together with GFAPɛ. Co-precipitation experiments from human cell extracts show GFAPɛ associates with RAP1, and immunolocalization studies in human SH-SY5Y cells reveal colocalization of RAP1, GFAPɛ, and PS1, supporting the notion of a cytoplasmic complex linking a telomeric protein to the γ-secretase machinery. Functional consequences of these interactions were tested in a genetic Saccharomyces cerevisiae model engineered to recapitulate γ-secretase activity. In yeast, expression of RAP1 increased γ-secretase activity, and this effect was potentiated by GFAPɛ, indicating that RAP1 and GFAPɛ act to enhance the proteolytic processing that generates Aβ peptides.

By demonstrating that the nuclear telomere factor RAP1 has an extratelomeric cytoplasmic role that modulates γ-secretase function, Bae and colleagues provide the first direct connection between RAP1 and an age-related disorder. The work situates RAP1 and GFAPɛ as potential modulators of Aβ production and highlights astrocyte-specific isoforms as contributors to APP processing dynamics. Given that aberrant γ-secretase activity and altered Aβ40:Aβ42 ratios underlie Alzheimer pathology, these findings open new avenues for understanding noncanonical regulators of presenilin function and for exploring how telomere-associated proteins might influence neurodegenerative disease mechanisms.

The study advances the concept that proteins classically involved in genomic maintenance can have meaningful cytoplasmic interactions with proteolytic complexes and supports further investigation into whether RAP1-GFAPɛ-PS1 interactions affect Aβ species ratios, plaque formation, or AD progression in mammalian systems.